Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: nunziodenora

Nunzio Denora received the degree in Chemistry and Pharmaceutical Technology at the University of Bari in 2001 and achieved his Ph.D. in Pharmaceutical Technology at the University of Palermo in 2004. After a postdoctoral position at the Pharmaceutical Chemistry Department of the Kansas University, US (2005-2006) under the supervision of Prof. Valentino J. Stella, he was appointed as assistant professor and research scientist of Pharmaceutical Technology at the Department of Pharmacy - Pharmaceutical Sciences of the University of Bari “Aldo Moro”. From 2019 he is associate professor of Pharmaceutical Technology heading a formulation research laboratory focusing in advanced drug delivery systems. Since 2016, he is heading the Inter-University Consortium CIRCSMB research group of Bari, Italy (> 30 scientists) and serves as Scientific Advisor for pharmaceutical companies. He is member of the Board ADRITELF Italy Chapter and scientific advisory board member for the European Paediatric Translational Research Infrastructure - EPTRI. His research is devoted to the development of paediatric formulations by conventional and/or innovative techniques.
February 21, 2022 Drug delivery / Pharma applications

Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug Niclosamide

Direct extrusion of hydroxypropyl beta-cyclodextrin (HP-β-CD)-based powder blends using the most innovative 3D printing technology, Direct Powder Extrusion (DPE), is

Continue reading

Recent Posts

  • New book on cyclodextrin glucanotransferase
  • Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin
  • Innovative Titanium Coatings for Enhanced Dental Implants
  • Bio-inks for skin regeneration: phase-adaptive design, multifunctional platforms, and 4D bioprinting frontiers
  • FermenGIN: γ-Cyclodextrin Takes the Bitterness Out of Bioconverted Red Ginseng

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (359)
  • CD derivatives (442)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (827)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,235)
  • Supramolecular systems (45)
  • Uncategorized (174)

Top Posts

  • New book on cyclodextrin glucanotransferase
  • Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin
  • Lanosterol eye drops for cataract treatment
  • Multiple therapeutic benefits of Sulforaphane/alpha-cyclodextrin complex
  • FermenGIN: γ-Cyclodextrin Takes the Bitterness Out of Bioconverted Red Ginseng
  • Toruzyme® for synthesizing cyclodextrins from starch
  • Effects of water matrix constituents on micropollutant removal by activated carbon and b-cyclodextrin polymer adsorbents
  • Gamma cyclodextrin / Theanine chewable developed for anxious pets
  • Advances in cyclodextrin-based materials: Anticancer and antimicrobial applications–A review (2021–2024)
  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...